Ardea Biosciences to Present Results from a Phase 2a Study of RDEA594 ...

Full story: Drugs.com

Sep 30, 2009 - Ardea Biosciences, Inc. today announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology / Association of Rheumatology Health Professionals Annual Scientific Meeting in Philadelphia, ...

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Allopurinol (generic), Zyloprim, Lopurin Discussions

Topic	Updated	Last By	Comments
Working to Improve on Allopurinol, the Standard...	Nov 30	popuppro	3
Diets High in Fructose are Raising Blood Pressu...	Nov 18	Home Boy	5
Ask Dr. Gott: Cherries a cure for kidney stone (Nov '08)	Jul '09	Mandye	2
New Pill Soothes Pain Of Those Suffering From Gout (May '09)	May '09	I Hate My Gout	1
New Gout Drug Gets FDA Panel Nod (Jan '09)	Jan '09	BorderDramaCom	2
Cherries help prevent kidney stones (Oct '08)	Nov '08	Jon	2
Management of acute and chronic gouty arthritis... (Aug '07)	Aug '07	Steve Williams	1